EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Cognitive and behavioral effects of perampanel 4 mg daily dose

Kimford J Meador, Jordan Seliger, Scheherazade Le, Yi Li, Babak Razavi, Jessica Falco-Walter, Alexa King, Edith Graham, Elizabeth Cunningham, Beth Leeman-Markowski, Alan Boyd, David W Loring und 1 weitere

Epilepsy & Behavior · 2025

DOI: 10.1016/j.yebeh.2025.110268 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Epilepsy & Behavior, 2025. Verfasst von Kimford J Meador und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology & Neurological Sciences, Stanford University Palo Alto CA United States. Electronic address: kmeador@stanford.edu. Hauptthemen laut MEDLINE: Pyridones, Anticonvulsants, Cognition. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Eisai Inc.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: The neuropsychological adverse effects of antiseizure medications (ASMs) influence the tolerability, and in turn effectiveness of these medications, which can occur in a dose-dependent fashion. In this study, we examine the neuropsychological effects of perampanel (PER) at 4 mg daily as this dose has not been previously assessed with objective cognitive tests. METHODS: The study was originally designed to assess (1) effects of perampanel at 4 mg using different titration rates, and (2) habituation over time. Due to the COVID-19 pandemic, the study was halted, limiting the sample size needed to analyze titration and habituation effects. Therefore, we compared the neuropsychological effects of perampanel 4 mg daily from non-drug baseline to the end of drug titration and end of drug maintenance in this randomized double-blind study of healthy volunteers. Treatment period was 6 weeks total with 2 weeks of variable titration followed by 4-week maintenance. Composite Z-scores were calculated by combining Z-scores from both cognitive (computerized and non-computerized) and behavioral tests. Secondary analyses were conducted on the independent cognitive and behavioral domain Z-scores, and on the raw scores from 19 items in the full battery. RESULTS: The overall composite Z-scores did not differ across baseline, the end of titration, and the end of maintenance. Similarly, individual cognitive and behavioral domain Z-scores did not differ across the three titration rates. Exploratory analyses of the raw scores were marginally significant on only two of the 19 neuropsychological measures. CONCLUSIONS: Perampanel 4 mg daily was well tolerated with few neuropsychological effects in healthy volunteers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyridonesAnticonvulsantsCognitionHumansNitrilesDouble-Blind MethodMaleAdultFemaleNeuropsychological TestsYoung AdultMiddle AgedDose-Response Relationship, Drug

Stichwörter der Autor:innen

Adverse effectsAntiseizure medicationsBehaviorCognitionPerampanel

Substanzen

perampanelNitrilesPyridonesAnticonvulsants

Autor:innen und Institutionen

  • Department of Neurology & Neurological Sciences, Stanford University Palo Alto CA United States. Electronic address: kmeador@stanford.edu.
  • Department of Neurology & Neurological Sciences, Stanford University Palo Alto CA United States. Electronic address: jseliger@stanford.edu.
  • Department of Neurology & Neurological Sciences, Stanford University Palo Alto CA United States. Electronic address: schele@stanford.edu.
  • Department of Neurology & Neurological Sciences, Stanford University Palo Alto CA United States. Electronic address: lyi@stanford.edu.
  • Department of Neurology & Neurological Sciences, Stanford University Palo Alto CA United States. Electronic address: brazavi@stanford.edu.
  • Department of Neurology & Neurological Sciences, Stanford University Palo Alto CA United States. Electronic address: Jessica.walter@stanford.edu.

Förderung

  • Eisai Inc

Zitieren

APA

Meador, K. J., Seliger, J., Le, S., Li, Y., Razavi, B., Falco-Walter, J., King, A., Graham, E., Cunningham, E., Leeman-Markowski, B., Boyd, A., Loring, D. W., & Gerard, E. (2025). Cognitive and behavioral effects of perampanel 4 mg daily dose. Epilepsy & Behavior. https://doi.org/10.1016/j.yebeh.2025.110268

Vancouver

Meador KJ, Seliger J, Le S, Li Y, Razavi B, Falco-Walter J, et al. Cognitive and behavioral effects of perampanel 4 mg daily dose. Epilepsy & Behavior. 2025. doi:10.1016/j.yebeh.2025.110268

BibTeX
@article{Meador2025,
  author = {Meador, Kimford J and Seliger, Jordan and Le, Scheherazade and Li, Yi and Razavi, Babak and Falco-Walter, Jessica and King, Alexa and Graham, Edith and Cunningham, Elizabeth and Leeman-Markowski, Beth and Boyd, Alan and Loring, David W and Gerard, Elizabeth},
  title = {Cognitive and behavioral effects of perampanel 4 mg daily dose},
  journal = {Epilepsy & Behavior},
  year = {2025},
  doi = {10.1016/j.yebeh.2025.110268}
}
Kostenlos starten →